Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers
Crossref DOI link: https://doi.org/10.1007/s40261-017-0614-0
Published Online: 2018-01-23
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rosenbaum, David P. http://orcid.org/0000-0002-9371-391X
Yan, Andrew
Jacobs, Jeffrey W.
Funding for this research was provided by:
Ardelyx, Inc.
License valid from 2018-01-23